D. Perner

Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir

S. Süsser, Johannes Vermehren, Nicole Forestier et al. · Journal of Clinical Virology · 2011 · 114 citations

Life Sciences, Infectious Diseases, Molecular Biology +15

Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients

Julia Dietz, S. Süsser, C. Berkowski et al. · PLoS ONE · 2015 · 74 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens

Benjamin Maasoumy, Johannes Vermehren, Martin‐Walter Welker et al. · Journal of Hepatology · 2016 · 66 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Interferon lambda 4 genotypes and resistance‐associated variants in patients infected with hepatitis C virus genotypes 1 and 3

Kai‐Henrik Peiffer, Lisa Sommer, S. Süsser et al. · Hepatology · 2015 · 46 citations

Life Sciences, Genetics, Molecular Genetics +17

Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection

Johannes Vermehren, S. Süsser, Annemarie Berger et al. · Journal of Clinical Virology · 2012 · 40 citations

Life Sciences, Infectious Diseases, Microbiology +17